Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
04/2002
04/11/2002CA2425126A1 Lipid metabolism enzymes
04/11/2002CA2424684A1 Nitroso diphenylamine derivatives
04/11/2002CA2424222A1 Inhibitors of prenyl-protein transferase
04/11/2002CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same
04/11/2002CA2423929A1 Carbohydrate-associated proteins
04/11/2002CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
04/11/2002CA2423462A1 Nectin polypeptides, polynucleotides, methods of making and use thereof
04/11/2002CA2423312A1 Condensed pyridoindole derivatives
04/10/2002EP1195161A2 Anti-IgE vaccines
04/10/2002EP1194563A1 Fimh adhesin-based vaccines
04/10/2002EP1194561A2 Donor strand complemented pilin and adhesin broad-based vaccines
04/10/2002EP1194525A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions
04/10/2002EP1194439A1 Human eag2
04/10/2002EP1194429A1 Potassium channel openers
04/10/2002EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
04/10/2002EP0950046B1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
04/10/2002EP0927150B1 Lipoxin compounds and their use in treating cell proliferative disorders
04/10/2002EP0819009B1 Ovulation triggering drugs comprising luteinising hormone
04/10/2002EP0732329B1 Chroman derivative
04/10/2002CN1344326A Petroviral vectors comprising functional and non-functional splice donor and splce acceptor sites
04/10/2002CN1344274A Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4
04/10/2002CN1344256A (Hetero) aryl-bicyclic heteroaryl derivatives, their prepn. and their use as protease inhibitors
04/10/2002CN1344247A Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
04/10/2002CN1344161A Use of pyridazino [4,5-i(b)]indole-1-acetamide derivatives for preparing medicines for treating disease related to dysfunction of peripheral benzodiazepin receptors
04/10/2002CN1344160A Heterocyclic aromatic compounds useful as growth hormone secretagogues
04/10/2002CN1344155A Transnasal transport/immunisation with highly adaptable carriers
04/10/2002CN1343518A Efficacy and application of soft capsule or oily pill prepared by mixing tomato seed oil with rubin
04/10/2002CN1343504A Composite medicine for treating nephrosis and its preparing process
04/09/2002US6369222 mGluR antagonists and a method for their synthesis
04/09/2002US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors
04/09/2002US6369084 Prostaglandin mediated diseases
04/09/2002US6369082 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
04/09/2002US6369059 Tetracyclic derivatives, process of preparation and use
04/09/2002US6369056 Agonists and antagonists of the progesterone receptor; contraceptives; 6-(3-chlorophenyl)-4,4-dimethyl-1,4-dihydro -3-oxa-1,8-diaza-naphthalene-2-one and 6-chloro-4,4-dimethyl-1,4-dihydro-3-oxa-1,5-diaza-naphthalen-2-one
04/09/2002CA2298572C Deuterated cyclosporine analogs and their use as immunomodulating agents
04/09/2002CA2090321C Therapeutically useful 2-aminotetralin derivatives
04/04/2002WO2002026781A2 Ige receptor antagonists
04/04/2002WO2002026733A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES
04/04/2002WO2002026729A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
04/04/2002WO2002026724A1 Cyclized benzamide neurokinin antagonists for use in therapy
04/04/2002WO2002026723A1 Compounds useful in the treatment of inflammatory diseases
04/04/2002WO2002026704A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(ene)oic acid as therapeutic agents
04/04/2002WO2002026256A1 Excessive antibody production inhibitors, process for producing the same and method of using the same
04/04/2002WO2002026245A2 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
04/04/2002WO2002026223A2 Catecholamine pharmaceutical compositions and methods
04/04/2002WO2002026214A1 Ion-strength independent sustained release pharmaceutical formulation
04/04/2002WO2002014281A8 Pyridine derivatives as inhibitors of p38
04/04/2002WO2002000167A3 Modified forms of pharmacologically active agents and uses therefor
04/04/2002WO2001094347A8 Tetracyclic diketopiperazine compounds as pdev inhibitors
04/04/2002WO2001090079A3 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
04/04/2002WO2001085980A3 Enzymatic assays for screening anti-cancer agents
04/04/2002WO2001072839A3 Human g-protein coupled receptors
04/04/2002WO2001055178A9 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
04/04/2002WO2001053353A3 Recombinant antibodies to human interkleukin-1 beta
04/04/2002WO2001049715A3 Methods and compositions for inhibiting neoplastic cell growth
04/04/2002WO2001044197A3 2-phenyl-quinoline derivatives and their use as contracting agent for smooth muscles
04/04/2002US20020040150 Skin treatment compositons containing a cationic polymer and a microparticle or nanoparticle vector
04/04/2002US20020040146 Useful as inhibitors of metalloproteases, e.g. zinc proteases, and which are effective in therapy of disease states associated with vasoconstriction
04/04/2002US20020040059 Controlling cancer by reducing its growth and improving response to therapy
04/04/2002US20020040048 (2S,4R)-4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid N'-isobutyl-N'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators
04/04/2002US20020040028 2-amine substituted quinoline or quinozoline derivatives useful for treating benign prostatic hyperplasia
04/04/2002US20020040016 Derivatives of azetidine and pyrrolidine
04/04/2002US20020040007 Novel macrolide antibiotics
04/04/2002US20020039996 Pharmaceutical administration form for peptides, process for its preparation, and use
04/04/2002US20020039736 Reacting aliphatic aminonitrile with water in presence of solid alumina catalyst to form lactam
04/04/2002DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use
04/04/2002DE10043846A1 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen 17-methyl steroids, processes for their preparation and pharmaceutical compositions containing this compound
04/04/2002CA2426666A1 Ion-strength independent sustained release pharmaceutical formulation
04/04/2002CA2424021A1 Catecholamine compositions and uses thereof
04/04/2002CA2423474A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(ene)oic acid as therapeutic agents
04/04/2002CA2423313A1 Methods of treating inflammatory and immune reactions and compositions therefor
04/04/2002CA2423305A1 Compounds useful in the treatment of inflammatory diseases
04/04/2002CA2423141A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
04/04/2002CA2421209A1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases
04/04/2002CA2420475A1 Ige receptor antagonists
04/03/2002EP1193268A1 Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases
04/03/2002EP1192951A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound
04/03/2002EP1192949A1 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient
04/03/2002EP1192261A1 22025, a novel human cyclic nucleotide phosphodiesterase
04/03/2002EP1192258A2 Human poly(adp-ribose) polymerase 2 materials and methods
04/03/2002EP1192257A2 Human regulators of intracellular phosphorylation
04/03/2002EP1192250A2 Human rna metabolism proteins (rmep)
04/03/2002EP1192163A1 DITHIEPINO 6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
04/03/2002EP1192161A2 Chromeno[4,3,2-de]isoquinolines as potent dopamine receptor ligands
04/03/2002EP1191944A2 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
04/03/2002EP1191943A1 Novel anti-allergic agents
04/03/2002EP1191941A1 A method for the prophylaxis and/or treatment of medical disorders
04/03/2002EP1191940A1 Tumor necrosis factor receptor 5
04/03/2002EP1191939A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
04/03/2002EP1191931A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
04/03/2002CN1343201A Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
04/03/2002CN1343174A 计量阀 Metering valve
04/03/2002CN1342480A Guben pill and its preparing process
04/03/2002CN1342458A Application of leflunomide in preparing medicines to treat lupoid nephritis and nephrotic syndrome
04/03/2002CN1342457A Method for preventing vomit and sexual disorder using tetrahydrobenzo [cd] indole-6-formylamine compound
04/02/2002US6365749 Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
04/02/2002US6365736 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
04/02/2002US6365715 Human cardiac/brain tolloid-like protein
04/02/2002US6365609 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
04/02/2002US6365599 For therapy of benign prostatic hyperplasia